Replies to post #123430 on Biotech Values

[DewDiligence]

FDA extends PDUFA date for Dapagliflozin by three months:

http://finance.yahoo.com/news/US-Food-and-Drug-bw-2761356853.html?x=0&.v=1

The new PDUFA date is 1/28/12. The advisory panel voted 9-6 against approval in July (#msg-65362040), so this seems like a longshot for approval on the first review cycle.